Search research articles
Contact Us
Filters
Showing results (51-60 of 148) with videos related to
Page
of 15
Sort By:
Stem Cell Research & Therapy
|
February 6, 2021
NAMPT/SIRT2-mediated inhibition of the p53-p21 signaling pathway is indispensable for maintenance and hematopoietic differentiation of human iPS cells
Yun Xu, Masoud Nasri, Benjamin Dannenmann, et al.
British Journal of Haematology
|
April 9, 2005
Heterogeneous expression pattern of pro- and anti-apoptotic factors in myeloid progenitor cells of patients with severe congenital neutropenia treated with granulocyte colony-stimulating factor
Gunnar Cario, Julia Skokowa, Zheng Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 19, 2005
Tumor necrosis factor and lymphotoxin alfa genetic polymorphisms and outcome in pediatric patients with non-Hodgkin's lymphoma: results from Berlin-Frankfurt-Münster Trial NHL-BFM 95
Kathrin Seidemann, Martin Zimmermann, Marion Book, et al.
Stem Cell Research & Therapy
|
October 20, 2023
Correction: NAMPT/SIRT2-mediated inhibition of the p53-p21 signaling pathway is indispensable for maintenance and hematopoietic differentiation of human iPS cells
Yun Xu, Masoud Nasri, Benjamin Dannenmann, et al.
Annals of Hematology
|
December 15, 2016
GM-CSF treatment is not effective in congenital neutropenia patients due to its inability to activate NAMPT signaling
Corinna Koch, Bardia Samareh, Tatsuya Morishima, et al.
Journal of Pediatric Hematology/Oncology
|
May 17, 2011
Oxaliplatin, irinotecan, and gemcitabine: a novel combination in the therapy of progressed, relapsed, or refractory tumors in children
Carolin Hartmann, Peter Weinel, Hansjörg Schmid, et al.
British Journal of Haematology
|
January 20, 2021
Nicotinamide (vitamin B3) treatment improves response to G-CSF in severe congenital neutropenia patients
Ekaterina Deordieva, Oksana Shvets, Kirill Voronin, et al.
Annals of the New York Academy of Sciences
|
February 22, 2020
New insights into the pathomechanism of cyclic neutropenia
Perihan Mir, Maksim Klimiankou, Betuel Findik, et al.
British Journal of Haematology
|
July 9, 2003
Expression and structural analysis of glucocorticoid receptor isoform gamma in human leukaemia cells using an isoform-specific real-time polymerase chain reaction approach
Carmela Beger, Katrin Gerdes, Melchior Lauten, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 3, 2004
Down-regulation of BRCA1 in chronic pancreatitis and sporadic pancreatic adenocarcinoma
Carmela Beger, Marco Ramadani, Stephan Meyer, et al.
Page
of 15
Search research articles
Search
Showing results (51-60 of 148) with videos related to
Sort By:
Page
of 15
Stem Cell Research & Therapy
|
February 6, 2021
NAMPT/SIRT2-mediated inhibition of the p53-p21 signaling pathway is indispensable for maintenance and hematopoietic differentiation of human iPS cells
Yun Xu, Masoud Nasri, Benjamin Dannenmann, et al.
British Journal of Haematology
|
April 9, 2005
Heterogeneous expression pattern of pro- and anti-apoptotic factors in myeloid progenitor cells of patients with severe congenital neutropenia treated with granulocyte colony-stimulating factor
Gunnar Cario, Julia Skokowa, Zheng Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 19, 2005
Tumor necrosis factor and lymphotoxin alfa genetic polymorphisms and outcome in pediatric patients with non-Hodgkin's lymphoma: results from Berlin-Frankfurt-Münster Trial NHL-BFM 95
Kathrin Seidemann, Martin Zimmermann, Marion Book, et al.
Stem Cell Research & Therapy
|
October 20, 2023
Correction: NAMPT/SIRT2-mediated inhibition of the p53-p21 signaling pathway is indispensable for maintenance and hematopoietic differentiation of human iPS cells
Yun Xu, Masoud Nasri, Benjamin Dannenmann, et al.
Annals of Hematology
|
December 15, 2016
GM-CSF treatment is not effective in congenital neutropenia patients due to its inability to activate NAMPT signaling
Corinna Koch, Bardia Samareh, Tatsuya Morishima, et al.
Journal of Pediatric Hematology/Oncology
|
May 17, 2011
Oxaliplatin, irinotecan, and gemcitabine: a novel combination in the therapy of progressed, relapsed, or refractory tumors in children
Carolin Hartmann, Peter Weinel, Hansjörg Schmid, et al.
British Journal of Haematology
|
January 20, 2021
Nicotinamide (vitamin B3) treatment improves response to G-CSF in severe congenital neutropenia patients
Ekaterina Deordieva, Oksana Shvets, Kirill Voronin, et al.
Annals of the New York Academy of Sciences
|
February 22, 2020
New insights into the pathomechanism of cyclic neutropenia
Perihan Mir, Maksim Klimiankou, Betuel Findik, et al.
British Journal of Haematology
|
July 9, 2003
Expression and structural analysis of glucocorticoid receptor isoform gamma in human leukaemia cells using an isoform-specific real-time polymerase chain reaction approach
Carmela Beger, Katrin Gerdes, Melchior Lauten, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 3, 2004
Down-regulation of BRCA1 in chronic pancreatitis and sporadic pancreatic adenocarcinoma
Carmela Beger, Marco Ramadani, Stephan Meyer, et al.
Page
of 15